Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Oct 2:57:102857.
doi: 10.1016/j.eucr.2024.102857. eCollection 2024 Nov.

Intravesical vancomycin for the treatment of Corynebacterium cystitis and struvite bladder stones: A case report

Jason E Michaud  1 , Christian C Morrill  2 , Ahmad Haffar  2 , Heather N Di Carlo  2 , John P Gearhart  2
Affiliations
Case Reports

Intravesical vancomycin for the treatment of Corynebacterium cystitis and struvite bladder stones: A case report

Jason E Michaud et al. Urol Case Rep. .

Abstract

Urologic patients with anatomic abnormalities can be particularly susceptible to urinary tract infections (UTI). UTI with urease-producing bacteria can promote struvite urinary calculi and pose unique treatment problems. There is potential for rapid stone growth and bacterial eradication can be difficult secondary to urothelial or stone colonization. Antibiotic resistance among urease-producing organisms further complicates treatment. In this report, we describe the use of intravesical vancomycin in the treatment of a patient with struvite bladder calculi secondary to urease-producing Corynebacterium urealyticum cystitis, resistant to enteral antibiotics. This highlights the potential of intravesical antibiotics for the treatment of UTI.

Keywords: Antibiotics; Bladder calculi; Exstrophy; Urease; Urinary tract infection.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts.

Figures

Fig. 1
Fig. 1
Struvite bladder stones from C. urealyticum UTI.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Flannigan R., Choy W.H., Chew B., Lange D. Renal struvite stones—pathogenesis, microbiology, and management strategies. Nat Rev Urol. 2014;11(6):333–341. doi: 10.1038/nrurol.2014.99. - DOI - PubMed
    1. Bichler K.H., Eipper E., Naber K., Braun V., Zimmermann R., Lahme S. Urinary infection stones. Int J Antimicrob Agents. 2002;19(6):488–498. doi: 10.1016/s0924-8579(02)00088-2. - DOI - PubMed
    1. Soriano F., Tauch A. Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2008;14(7):632–643. doi: 10.1111/j.1469-0691.2008.02023.x. - DOI - PubMed
    1. Cappuccino L., Bottino P., Torricella A., Pontremoli R. Nephrolithiasis by Corynebacterium urealyticum infection: literature review and case report. J Nephrol. 2014;27(2):117–125. doi: 10.1007/s40620-014-0064-1. - DOI - PubMed
    1. Pietropaolo A., Jones P., Moors M., Birch B., Somani B.K. Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): a systematic review. Curr Urol Rep. 2018;19(10):78. doi: 10.1007/s11934-018-0834-8. - DOI - PMC - PubMed

Publication types

LinkOut - more resources